Projects per year
Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 10 Similar Profiles
Lymphoma
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Follicular Lymphoma
Medicine & Life Sciences
Phosphotransferases
Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse
Medicine & Life Sciences
Non-Hodgkin's Lymphoma
Medicine & Life Sciences
T-Cell Lymphoma
Medicine & Life Sciences
Anaplastic Large-Cell Lymphoma
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2014 2019
- 1 Active
A New Treatment Paradigm for ALK-Driven Cancers Exploiting Oncogene Overdose
9/19/14 → 8/31/19
Project: Research project
Oncogenes
Neoplasms
Phosphotransferases
Therapeutics
Anaplastic Large-Cell Lymphoma
Research Output 2006 2019
Short survival and frequent transformation in extranodal marginal zone lymphoma with multiple mucosal sites presentation
Alderuccio, J. P., Zhao, W., Desai, A., Ramdial, J., Gallastegui, N., Kimble, E., de la Fuente, M. I., Husnain, M., Rosenblatt, J. D., Alencar, A. J., Schatz, J. H., Moskowitz, C. H., Chapman, J. R., Vega, F., Reis, I. M. & Lossos, I. S., Jan 1 2019, In : American Journal of Hematology.Research output: Contribution to journal › Article
Lymphoma
Survival
Paraproteinemias
Disease-Free Survival
Marginal Zone B-Cell Lymphoma
EIF4A inhibition: Ready for primetime?
Cunningham, T. A., Chapman, E. & Schatz, J. H., Oct 1 2018, In : Oncotarget. 9, 85, p. 35515-35516 2 p.Research output: Contribution to journal › Editorial
Drug Discovery
3
Citations
(Scopus)
Statins enhance efficacy of venetoclax in blood cancers
Lee, J. S., Roberts, A., Juarez, D., Vo, T. T. T., Bhatt, S., Herzog, L. O., Mallya, S., Bellin, R. J., Agarwal, S. K., Salem, A. H., Xu, T., Jia, J., Li, L., Hanna, J. R., Davids, M. S., Fleischman, A. G., O'Brien, S., Lam, L. T., Leverson, J. D., Letai, A. & 2 others, Jun 13 2018, In : Science Translational Medicine. 10, 445, eaaq1240.Research output: Contribution to journal › Article
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Neoplasms
Oxidoreductases
Protein Prenylation
Apoptosis
2
Citations
(Scopus)
Target-based screening against eIF4A1 reveals the marine natural product elatol as a novel inhibitor of translation initiation with in vivo antitumor activity
Peters, T. L., Tillotson, J., Yeomans, A. M., Wilmore, S., Lemm, E., Jimenez-Romero, C., Amador, L. A., Li, L., Amin, A. D., Pongtornpipat, P., Zerio, C. J., Ambrose, A. J., Paine-Murrieta, G., Greninger, P., Vega, F., Benes, C. H., Packham, G., Rodríguez, A. D., Chapman, E. & Schatz, J. H., Sep 1 2018, In : Clinical Cancer Research. 24, 17, p. 4256-4270 15 p.Research output: Contribution to journal › Article
Biological Products
Neoplasms
DEAD-box RNA Helicases
Heterografts
Adenosine Triphosphatases
1
Citation
(Scopus)
Yttrium-90-Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy after Cytoreduction with ESHAP Chemotherapy in Patients with Relapsed Follicular Non-Hodgkin Lymphoma: Final Results of a Phase II Study
Puvvada, S. D., Guillén-Rodríguez, J. M., Yan, J., Inclán, L., Heard, K., Rivera, X. I., Anwer, F. ., Mahadevan, D., Schatz, J. H. & Persky, D. O., Feb 22 2018, (Accepted/In press) In : Oncology (Switzerland).Research output: Contribution to journal › Article
Radioimmunotherapy
Follicular Lymphoma
Non-Hodgkin's Lymphoma
Disease-Free Survival
Drug Therapy